hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Matteo Donadon, MD, PhD

    Associate Professor of Surgery, Università del Piemonte Orientale, Novara, Italy;
    Director, Surgical Oncology Program, University Maggiore Hospital, Novara, Italy.

Speaker(s)

  • Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA

    Professor and Chair, Department of Surgery;
    The Urban Meyer III and Shelley Meyer Chair for Cancer Research;
    Wexner Medical Center at The Ohio State University, Columbus, OH, USA.
    Topic: Translational Research in Liver Tumors: the Surgeon's Perspective

  • Domenico Mavilio, MD, PhD

    Full Professor of Translational Medicine, Department of Medical Biotechnologies and Translational Medicine, Medical School of Milan University,Milan, Italy;
    Principal Investigator Head, Unit of Clinical and Experimental Immunology, Humanitas Research Hospital, Rozzano, Milan, Italy;
    Adjunct Investigator, Laboratory of Cardiovascular Regenerative Medicine, National Hearth, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
    Topic: Research on NK and VδT Lymphocytes in HCC

  • David James Pinato, MD, PhD

    Director of Developmental Cancer Therapeutics, Clinical Senior Lecturer and Consultant Medical Oncologist at Imperial College London, London, United Kingdom.
    Topic: Immunotherapy in HCC

  • Ana Lleo, MD, PhD

    Professor of Internal Medicine - Humanitas University;
    Consultant Hepatologist, Division of Internal Medicine and Hepatology - Humanitas Research Hospital;
    Group Leader, Hepatobiliary Immunopathology Lab - Humanitas Research Center.
    Topic: Dissecting the Immune Infiltrate in CCA

  • Lorenza Rimassa, MD.

    Associate Professor of Medical Oncology, Department of Biomedical Sciences, Humanitas University, Milan, Italy;
    Director of the Residency Program in Medical Oncology, Humanitas University, Milan, Italy;
    Head of the Hepatopancreatobiliary Section, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.
    Topic: Immunotherapy in CCA

Programme

      Time (CET)
      Speakers
      Topics
      14:00-14:15
      Chair (Matteo Donadon)
      Introduction to the webinar
      14:15-14:30
      Timothy Pawlik
      Translational research in liver tumors: the surgeon's perspective
      14:30-14:45
      Domenico Mavilio
      Research on NK and VδT lymphocytes in HCC
      14:45-15:00
      David James Pinato
      Immunotherapy for HCC
      15:00-15:15
      Ana Lleo
      Dissecting the immune infiltrate in CCA
      15:15-15:30
      Lorenza Rimassa
      Immunotherapy in CCA
      15:30-15:50
      Chair (Matteo Donadon)
      Discussion (Q&A)
      15:50-16:00
      Chair (Matteo Donadon)
      Concluding remarks
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties